Cessation Therapeutics
San Jose, US · Founded 2022 · Delaware corporation
Cessation Therapeutics develops immunotherapies, including monoclonal antibodies and vaccines, to treat substance use disorders and counter the effects of opioids such as fentanyl and heroin. The company works on medications aimed at preventing opioid overdose deaths.
Founders & leadership
Cessation Therapeutics was founded in 2022 by John D. Harkey, Jr..
JD
John D. Harkey, Jr.Co-Founder & Board Member
JS
Jay ShepardNamed on SEC filing
MP
Mark PearsonCo-Founder & Board Member
JH
John HarkeyNamed on SEC filing
DG
David GenecovCo-Founder, Former Chief Medical Officer & Board Member
ER
Eric RasmussenNamed on SEC filing
PB
Paul BremerResearch and Development Director
JK
John KatsilometesController
AB
Andrew BarrettBoard Member, former Chief Scientific Officer
Reported raises · per SEC filings
Form D private placements$6.8M disclosed across 2 rounds · 2022–2024
▶$1MraisedApr 2024 · 2 investors · BiotechnologyRule 506(b)
▶$1MraisedApr 2024 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrew BarrettExecutive Officer
- Sharon TetlowDirector
- John HarkeyDirector
- Daniel FineDirector
- Jay ShepardDirector
- Mark PearsonDirector
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$5.8MraisedMay 2022 · 31 investors · BiotechnologyRule 506(c)
▶$5.8MraisedMay 2022 · 31 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Jay ShepardDirector
- Mark PearsonExecutive Officer, Director
- John HarkeyExecutive Officer, Director
- David GenecovDirector
- Eric RasmussenExecutive Officer
- Offering amount
- $10M
- Amount sold
- $5.8M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Practo3 shared keywordsPracto is a healthcare platform offering online video consultations with verified doctors across specialties and appointment booking for in-clinic visits. It serves patients in India, connecting them with doctors across areas such as dentistry, gynecology, pediatrics, and general medicine.
Zocdoc3 shared keywordsZocdoc runs an online marketplace where US patients find in-network doctors and dentists and book in-person or telehealth appointments.
Companies competing with Cessation Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Cessation Therapeutics do?
- Cessation Therapeutics develops immunotherapies, including monoclonal antibodies and vaccines, to treat substance use disorders and counter the effects of opioids such as fentanyl and heroin. The company works on medications aimed at preventing opioid overdose deaths.
- Who founded Cessation Therapeutics?
- Cessation Therapeutics was founded by John D. Harkey, Jr. in 2022.
- How much funding has Cessation Therapeutics raised?
- Cessation Therapeutics has disclosed $6.8M raised across 2 rounds.
- Where is Cessation Therapeutics headquartered?
- Cessation Therapeutics is headquartered in San Jose, US.